Mitsubishi Chemical Group (MTLHY) Fair Value & Analysis
Basic Materials · US · Market cap $9.4B
Analysis
Mitsubishi Chemical Group (MTLHY) currently trades at $34.70, while our model-based Fair Value estimate is $39.17 — implying the stock looks roughly 12.9% undervalued today. We read business quality at 82/100 (high quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
About the company
Mitsubishi Chemical Group Corporation engages in the manufacture and sale of performance products, industrial materials, and other products. It operates through four segments: Specialty Materials, MMA & Derivatives, Basic Materials & Polymers, and Industrial Gases. The company offers chemical products, such as industrial chemicals, basic petrochemicals, solvents, MMA monomer and derivatives, and acrylonitrile and related products; film and sheet/molding/composite products, including supplemental materials and adhesives, composite materials, synthetic paper, and materials used in production; and battery materials, recording materials and recording media, display materials, imaging materials, lighting materials, information materials, semiconductor materials, and insulating materials. It also provides environment and living solution comprising water treatment, water purifier, separation materials/synthetic adsorbents, civil engineering materials, building materials, equipment and mach…
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.